CPI-818 Data Highlights Potential for ITK Inhibition as a New Immunotherapy Approach for the Treatment of T Cell Lymphoma
Interim data from Phase 1/1b clinical trial of CPI-818, including new evidence supporting the recently…
Interim data from Phase 1/1b clinical trial of CPI-818, including new evidence supporting the recently…
Interim data from Phase 1/1b clinical trial of CPI-818, including new evidence supporting the recently…
YONKERS, New York, April 03, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage…
YONKERS, New York, April 03, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage…
Revenue Increases 343% for 2022 Due to Increased Number of Patients Treated at Licensed Clinics…
Revenue Increases 343% for 2022 Due to Increased Number of Patients Treated at Licensed Clinics…
ROCHESTER, N.Y., April 03, 2023 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the…
ROCHESTER, N.Y., April 03, 2023 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the…
Carlsbad, CA, April 03, 2023 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing…
Carlsbad, CA, April 03, 2023 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing…
HCW Biologics Published a Pivotal Scientific Paper in Aging Cell Subcutaneous Administration of HCW9218 Systemically…
HCW Biologics Published a Pivotal Scientific Paper in Aging Cell Subcutaneous Administration of HCW9218 Systemically…
PDS Biotech prepares to advance PDS0101 into a Phase 3 registrational clinical trial – VERSATILE-003…
PDS Biotech prepares to advance PDS0101 into a Phase 3 registrational clinical trial – VERSATILE-003…
NAARDEN, the Netherlands and MIAMI, April 03, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V….
NAARDEN, the Netherlands and MIAMI, April 03, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V….
Horus to increase ILUVIEN commercial presence with Nordic Retinal Specialists ATLANTA, April 03, 2023 (GLOBE…
Horus to increase ILUVIEN commercial presence with Nordic Retinal Specialists ATLANTA, April 03, 2023 (GLOBE…
NEW YORK and LONDON, April 03, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
NEW YORK and LONDON, April 03, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…